FDA Grants Breakthrough Device Designation to HLA-LOH Companion Diagnostic Test

The FDA has granted a breakthrough device designation to HLA-LOH as a companion diagnostic test, according to an announcement from Tempus.

Related Keywords

Kate Sasser ,Tempus Labs Inc , ,Colorectal Cancer ,Crc ,Fda ,Fast Track Designation ,Hla Loh Companion Diagnostic ,